Pages that link to "Q67522252"
Jump to navigation
Jump to search
The following pages link to The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosets (Q67522252):
Displaying 12 items.
- NMDA receptors in the basal ganglia (Q33989361) (← links)
- Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. (Q41334106) (← links)
- Behavioural pharmacology of glutamate receptors in the basal ganglia (Q41509236) (← links)
- Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease (Q41509262) (← links)
- Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease (Q41509268) (← links)
- Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action (Q41509280) (← links)
- Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice (Q48152487) (← links)
- Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. (Q48818709) (← links)
- A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease (Q64767865) (← links)
- Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse (Q71815311) (← links)
- Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist (Q71859363) (← links)
- Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice (Q72584434) (← links)